Clinical Trial Updates: Early Data on Remdesivir for Severe COVID-19
April 29, 2020
New clinical trial updates on remdesivir as a potential treatment for coronavirus disease 2019 (COVID-19) were announced today.
Respiratory Diseases
Temple University Hospital Begins Clinical Trial of Gimsilumab for Combatting COVID-19
April 16, 2020
In 2 prior clinical studies, gimsilumab demonstrated favorable results in treating the novel coronavirus.
Children May Not Always Have Fever, Cough with COVID-19 Infection
April 9, 2020
Children with the novel coronavirus disease 2019 (COVID-19) may not develop a fever or cough as often as adults with the virus.
Study Investigates COVID-19 Mortality, Early Indicators of Poor Prognosis
April 8, 2020
As COVID-19 continues to spread, and the death toll rises, experts aim to better understand the clinical features of the disease and factors for increased mortality.
Incyte, Novartis Plan Phase 3 Trial for Ruxolitinib in COVID-19
April 6, 2020
The study will evaluate ruxolitinib (Jakavi) for the treatment of COVID-19-associated cytokine storm.
FDA OKs Nintedanib for Progressive Interstitial Lung Diseases
March 10, 2020
Nintedanib (Ofev, Boehringer Ingelheim Pharmaceuticals) has been approved for the treatment of chronic fibrosing interstitial lung disease with a progressive phenotype.
FDA Requests Withdrawal of Bacitracin Injection from Market
February 3, 2020
The FDA is requesting that manufacturers of bacitracin for injection voluntarily withdraw their product.
Wearable Device Data May Help Identify Flu Trends, Predict Outbreaks
January 28, 2020
Data tracked by wearable fitness sensors may help with real-time surveillance of seasonal respiratory infections, such as influenza.
CDC: 2 Novel Coronavirus Cases Reported in US, Risk to Public Is Still Low
January 24, 2020
The 2019 Novel Coronavirus outbreak in Wuhan City, China has caused concern as 2 cases have been recently reported in the United States.
Lefamulin (Xenleta) for Community Acquired Bacterial Pneumonia
January 21, 2020
Lefamulin was approved by the FDA in August 2019 for the treatment of CABP.
